Connexin43 cardiac gap junction remodeling: lessons from genetically engineered murine models

Benjamin F Remo1, Steven Giovannone, Glenn I Fishman

  • 1Leon H. Charney Division of Cardiology, New York University School of Medicine, 522 First Avenue, Smilow 801, New York, NY 10016, USA.

Insights

Cardiac gap junction remodeling, particularly connexin43 phosphorylation, is a key factor in sudden cardiac death and arrhythmias. Our research in mouse models explores these mechanisms and their proarrhythmic effects.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Sudden cardiac death causes hundreds of thousands of deaths annually in the US.
  • Cardiac gap junction remodeling is implicated in the development of life-threatening cardiac arrhythmias.
  • Connexin43 (Cx43) is a critical gap junction protein in the heart.

Purpose of the Study:

  • To investigate the mechanisms underlying pathological cardiac gap junction remodeling.
  • To explore the proarrhythmic consequences of altered gap junction function.
  • To focus on the role of connexin43 posttranslational modifications, specifically phosphorylation.

Main Methods:

  • Utilized genetically engineered murine models to study cardiac gap junctions.
  • Examined alterations in gap junction expression and function.
  • Investigated aberrant posttranslational phosphorylation of connexin43.

Main Results:

  • Perturbation of gap junction expression and function contributes to cardiac arrhythmias.
  • Aberrant phosphorylation of connexin43 is a key mechanism in pathological remodeling.
  • These changes lead to proarrhythmic consequences.

Conclusions:

  • Cardiac gap junction remodeling, especially Cx43 phosphorylation, is a significant contributor to sudden cardiac death.
  • Understanding these mechanisms in mouse models provides insights into human cardiac arrhythmias.
  • Targeting connexin43 phosphorylation may offer therapeutic strategies for preventing arrhythmias.